Toister, E.; Cherry, L.; Lupu, E.; Monash, A.; Dor, E.; Levin, L.; Girshengorn, M.; Natan, N.; Chapman, S.; Shmaya, S.;
et al. Development and Validation of a Plaque Assay to Determine the Titer of a Recombinant Live-Attenuated Viral Vaccine for SARS-CoV-2. Vaccines 2024, 12, 374.
https://doi.org/10.3390/vaccines12040374
AMA Style
Toister E, Cherry L, Lupu E, Monash A, Dor E, Levin L, Girshengorn M, Natan N, Chapman S, Shmaya S,
et al. Development and Validation of a Plaque Assay to Determine the Titer of a Recombinant Live-Attenuated Viral Vaccine for SARS-CoV-2. Vaccines. 2024; 12(4):374.
https://doi.org/10.3390/vaccines12040374
Chicago/Turabian Style
Toister, Einat, Lilach Cherry, Edith Lupu, Arik Monash, Eyal Dor, Lilach Levin, Meni Girshengorn, Niva Natan, Shira Chapman, Shlomo Shmaya,
and et al. 2024. "Development and Validation of a Plaque Assay to Determine the Titer of a Recombinant Live-Attenuated Viral Vaccine for SARS-CoV-2" Vaccines 12, no. 4: 374.
https://doi.org/10.3390/vaccines12040374
APA Style
Toister, E., Cherry, L., Lupu, E., Monash, A., Dor, E., Levin, L., Girshengorn, M., Natan, N., Chapman, S., Shmaya, S., Epstein, E., Adar, Y., Zichel, R., Ophir, Y., & Diamant, E.
(2024). Development and Validation of a Plaque Assay to Determine the Titer of a Recombinant Live-Attenuated Viral Vaccine for SARS-CoV-2. Vaccines, 12(4), 374.
https://doi.org/10.3390/vaccines12040374
